Lung Cancer Non-Small Cell Cancer (NSCLC) Enrolling by Invitation Phase 2 Trials for Regorafenib (DB08896)

Also known as: Carcinoma, Non-Small-Cell-Lung Cancer / Non-Small Cell Carcinoma of Lung / Carcinoma, Non-small Cell Lung Cancer / Carcinoma, Non-Small Cell-Lung / Non Small Cell Carcinoma of the Lung / NSCLC Non Small Cells Lung Cancer / Lung Carcinomas, Non-Small-Cell / Lung Non-Small Cell Carcinoma / Carcinoma´╝îNon-Small-Cell Lung / Carcinoma, Non-Small-Cell-Lung / Carcinoma Non-small-cell Lung / Carcinoma, Non-Small -Cell Lung / Non-small Cell Lung Cancer, NSCLC / Non-small-lung-cell Cancer, NSCLC / Non-small-cell-lung-cancer (NSCLC) / Non-small Cell Lung Cancer NSCLC / NSCLC (Non-small Cell Lung Carcinoma) / Non Small Cell Lung Carcinoma NSCLC / Carcinoma, Non Small Cell Lung (NSCLC) / Carcinoma, Non-Small-Cell Lung (NSCLC) / Non-Small-Cell Lung Carcinoma NSCLC / Non Small Cell Lung Carcinoma (NSCLC) / Carcinoma, Non Small Cell Lung / Non Small Cell Lung Carcinoma / Non Small Cell Lung Cancer NSCLC / Lung Cancer - Non Small Cell / Non- Small Cell Lung Cancer / Non-Small Cell Lung Cancer(NSCLC) / NSCLC / Lung Cancer, Non-Small Cell / Non-Small Cell Lung Carcinoma (NSCLC) / Lung Cancer Non-Small Cell / Lung Cancer, Nonsmall Cell / Non-Small-Cell-Lung Cancer / Non-Small-Cell-Lung Cancer (NSCLC) / Non - Small Cell Lung Cancer NSCLC / Nonsmall Cell Lung Cancer / Non-Small Cell Lung Cancer / Non-Small-Cell Lung Cancer (NSCLC) / NSCLC (Non-Small Cell Lung Cancer) / Lung Cancer (Non-Small Cell) / NSCLC, Non Small Cell Lung Cancer / Non-small Cell Lung Cancers / Non-Small Cell Lung Carcinoma / Non-Small-Cell Lung Cancer / Non-Small Cell Lung Cancer (NSCLC) / Non Small Cell Lung Cancer / Carcinoma, Non-Small Cell Lung / Non Small-cell Lung Cancer / NSCLC Non-small Cell Lung Cancer / Non Small Cells Lung Cancer / Lung Cancer (NSCLC) / Carcinoma, Non-Small-Cell Lung / Non-Small-Cell Lung Carcinoma (NSCLC) / Non-Small-Cell Lung Carcinoma / Lung Cancer(NSCLC) / Non Small Cell Lung Cancer (NSCLC) / Non-small cell lung cancer (disorder) / Non-small cell lung cancer NOS

IndicationStatusPhase
DBCOND0046916 (Lung Cancer Non-Small Cell Cancer (NSCLC))Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs